Introducing Univfy, a leading brand in the field of fertility treatments and reproductive medicine. Utilizing cutting-edge AI technology, the Univfy AI Platform offers women and couples a comprehensive solution to navigate their family-building options. With a focus on cost-savings, greater success rates, and a simplified experience, Univfy empowers individuals to make informed decisions and maximize their chances of success.

At the core of Univfy's offerings is the Univfy PreIVF Report, a personalized and scientifically-validated prognostics tool. This report provides each patient with their own probability of having a baby through up to three IVF cycles. Factors such as age, BMI, reproductive history, ovarian reserve test results, and partner's semen analysis are taken into account to provide accurate predictions.

In fact, Univfy's technology has shown that more than 50% of patients have higher IVF success probabilities than estimated by age alone. Univfy's commitment to scientific research and innovation is evident in their extensive portfolio of published studies. Collaborating with researchers from Stanford University, Univfy has developed and validated prediction models that have set benchmarks in the industry.

Founded by Dr. Mylene Yao, a renowned expert in reproductive medicine, and Professor Wing H. Wong, a distinguished statistician, Univfy has gained recognition for its groundbreaking approach to fertility treatments.

With their global IP portfolio and commitment to patient-centered care, Univfy is revolutionizing the field of fertility medicine. Contact Univfy today to discover your personalized path to parenthood